PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.765
https://www.valueinhealthjournal.com/article/S1098-3015(19)33143-2/fulltext
Section Title :
Section Order :
10669
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33143-2&doi=10.1016/j.jval.2019.09.765